Article
Estrogen receptor mutations in breast cancer.
Journal of cellular biochemistry - 1 Feb 1993
Fuqua S A, Chamness G C, McGuire W L
Abstract excerpt
It is fairly well accepted that the presence of estrogen receptor (ER) identifies those breast cancer patients with a lower risk of relapse and better overall survival [Clark and McGuire, 1988], and the measurement of ER has become a standard assay in the clinical management of breast cancer. Receptor status also provides a guideline for those tumors which may be responsive to hormonal intervention [McGuire 1978;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
